FDA cleared the SwiftMR from Airs Medical, Inc. on Jul 24, 2026 under K261349, a traditional 510(k). The device falls under product code QIH, Automated Radiological Image Processing Software, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.

FDA logged the submission as received on Apr 24, 2026. The decision came 91 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Airs Medical, Inc. has 2 other decisions in the tracker over the last 12 months: K253775 (SwiftMR), K251483 (SwiftSight-Brain).